Consolidated Balance Sheets - USD ($) $ in Millions		Sep. 30, 2019	Sep. 30, 2018
Current assets
Cash and cash equivalents		$ 232	$ 294
Accounts receivable	[1]	481	522
Inventories - Note A		597	596
Other assets		64	60
Current assets held for sale - Note D		59	240
Total current assets		1,433	1,712
Property, plant and equipment - Note H
Cost		3,165	3,172
Accumulated depreciation		1,588	1,526
Net property, plant and equipment		1,577	1,646
Goodwill - Note I		2,253	2,304
Intangibles - Note I		1,088	1,185
Restricted investments - Note G		310	312
Asbestos insurance receivable - Note O		157	179
Deferred income taxes - Note M		23	28
Other assets - Note K		410	416
Noncurrent assets held for sale - Note D			477
Total noncurrent assets		5,818	6,547
Total assets		7,251	8,259
Current liabilities
Short-term debt - Note J		166	254
Trade and other payables		313	331
Accrued expenses and other liabilities		271	328
Current liabilities held for sale - Note D		7	163
Total current liabilities		757	1,076
Noncurrent liabilities
Long-term debt - Note J		1,501	2,275
Asbestos litigation reserve - Note O		555	612
Deferred income taxes - Note M		264	286
Employee benefit obligations - Note N		150	156
Other liabilities - Note K		453	422
Noncurrent liabilities held for sale - Note D			26
Total noncurrent liabilities		2,923	3,777
Commitments and contingencies - Notes L and O
Equity - Notes P and Q
Common stock, par value $.01 per share, 200 million shares authorized Issued 60 million and 62 million shares in 2019 and 2018		1	1
Paid-in capital		756	946
Retained earnings		3,224	2,750
Accumulated other comprehensive loss		(410)	(291)
Total equity		3,571	3,406
Total liabilities and equity		$ 7,251	$ 8,259

[1] Accounts receivable includes an allowance for doubtful accounts of $3 million at both September 30, 2019 and 2018.